#404 ‒ Mental health beyond neurotransmitters: the role of hormones in psychiatry, why symptom reduction isn't enough, and the future of psychedelic therapies | Linus Abrams, M.D.
In this episode, Peter sits down with Dr. Linus Abrams, a psychiatrist with nearly 35 years of clinical experience specializing in mood disorders and psychopharmacology, to explore how our understanding of mental health is evolving beyond the traditional neurotransmitter model. After decades in practice, Linus began questioning many of the assumptions underlying modern psychiatry, leading him to investigate how hormones, metabolism, inflammation, circadian biology, and the endocrine system shape mood and cognition. Together, Peter and Linus examine why psychiatric care should aim not only to reduce symptoms but also to restore the full human experience. They discuss how psychiatric medications work, where they fall short, and why distinguishing bipolar disorder from unipolar depression is essential for effective treatment. The conversation also explores the growing mental health burden of social isolationn associated with digital devices and social media, along with the biological factors—nutrition, exercise, sleep, and chronic stress—that influence resilience and distress tolerance. Linus explains the powerful roles of estrogen, progesterone, testosterone, and thyroid hormone in regulating mood and cognition across the lifespan. Finally, Peter and Linus review the promise and limitations of ketamine and psychedelic therapies, and why the future of psychiatry may lie in integrating neuroscience, endocrinology, and whole-body physiology to better understand, diagnose, and treat mental illness.
We discuss:
Linus's passion for understanding his patients and going beyond traditional psychiatry [2:45];
A short primer on the different classes of drugs used in psychiatry [12:45];
Evaluation of a patient with bipolar disorder [26:00];
An evolutionary perspective on depression [33:30];
Changes in the modern world triggering mental health problems [41:00];
An evolutionary perspective on insomnia [48:15];
Peter's window analogy to understand distress tolerance and irritability [49:45];
The impact of foundational biological factors on psychiatry: nutrition, exercise, sleep, and endocrinology [52:30];
The effect of estradiol on neurotransmitters in the brain [58:15];
Options for increasing testosterone in men, and why clomiphene is inferior to exogenous testosterone [1:11:00];
The rapid drop in progesterone is linked to both premenstrual dysphoric disorder (PMDD) and postpartum depression [1:14:30];
Treatment of postpartum depression [1:18:00];
Hypothyroidism presenting as depression: how Linus makes the diagnosis and what he uses for treatment [1:26:00];
The link between hyperarousal and chronically elevated cortisol [1:39:30];
A case where the menopause transition uncovers bipolar disorder [1:44:15];
Ketamine as a tool to treat recalcitrant depression, and concerns about its recreational use [1:49:15];
Case study: an Alzheimer's patient who improved after psilocybin, and why Linus is cautious about drawing conclusions from it [1:55:15];
Peter's experience with psychedelics, and the myth that estrogen is bad for men [2:00:30];
The therapeutic potential of psychedelics in psychiatry [2:11:00]; and
Podden och tillhörande omslagsbild på den här sidan tillhör
Peter Attia, MD. Innehållet i podden är skapat av Peter Attia, MD och inte av,
eller tillsammans med, Poddtoppen.
